SynthesisNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Effect of surface electromyographic biofeedback on post-stroke dysphagia: a meta-analysis.
Synthesis in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study aimed to explore the efficacy of surface electromyography biofeedback (sEMG-BF) in treating post-stroke dysphagia (PSD) patients.
methodsPubMed, EMBASE, Cochrane Library, CINAHL, and Web of Science were searched from database inception to April 2024. Randomized controlled trials (RCTs) investigating the effects of sEMG-BF on patients with PSD were included. Risk of bias was assessed using the Cochrane Risk of Bias tool for RCTs. The level of oral intake was measured by the Functional Oral Intake Scale (FOIS). The penetration and aspiration were measured by the Penetration-Aspiration Scale (PAS), and clinical efficacy rate. Meta-analysis was performed using R software with random-effects models.
resultsFive RCTs involving 174 patients were included. sEMG-BF showed borderline improvement in oral intake (MD = 1.26, 95% CI: 0.03–2.48, P = 0.047). Nonetheless, due to significant heterogeneity (I2 = 62%) and the limited number of studies, it was impossible to draw definitive conclusions about optimal timing or protocol. No significant improvement in penetration and aspiration was observed (MD = -0.70, 95% CI: -1.46–0.07, P = 0.198), suggesting no consistent effect on objective swallowing safety, with low heterogeneity (I2 = 0%, P = 0.57). The clinical efficacy rate was improved (RR = 1.26, 95% CI: 0.98–1.62, P = 0.066)in the sEMG-BF group compared to the control group, with low heterogeneity (I2 = 0%, P = 0.93).
conclusionCurrent preliminary evidence suggests potential benefits of sEMG-BF in improving functional oral intake, though only borderline statistical significance is observed. sEMG-BF may improve swallowing function in post-stroke dysphagia. However, give few trials included and heterogeneous protocols, its definitive efficacy, optimal implementation, and generalizability need to be validated in large-scale randomized controlled trials with standardized, reproducible protocols.
Indexed as
Identifiers
41857464What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.